Cabot Corp (CBT) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Cabot Corp (CBT) stock forecast summary
Our AI scores Cabot Corp every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Cabot Corp is a mid-cap company with a market capitalization of $3.67B. It ranks number 2 by market capitalization among the 9 Miscellaneous Chemical Products issuers in our coverage with a current forecast.
For CBT, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 21.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -4.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CBT included.
CBT price chart and AI forecast
How CBT ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cabot Corp (CBT) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Miscellaneous Chemical Products peers listed below that report each metric.
Valuation & Market
| Metric | CBT | Rank |
|---|---|---|
| Market Cap | $3.67B | 2/9 |
| P/E Ratio | 19.96x | – |
| P/B Ratio | 2.29x | 4/8 |
| Dividend Yield | 2.64% | – |
| EPS | $3.56 | – |
| Book Value/Share | $31.09 | – |
| Revenue/Share | $70.38 | – |
| FCF/Share | $5.44 | – |
Profitability & Margins
| Metric | CBT | Rank |
|---|---|---|
| ROE | 11.8% | 3/6 |
| ROA | 4.8% | 3/7 |
| ROIC | 17.4% | 3/8 |
| Gross Margin | 22.7% | 7/9 |
| Operating Margin | 13.6% | 2/9 |
| Net Margin | 5.2% | 4/7 |
| EBT Margin | 11.5% | 3/9 |
| Tax Rate | 45.5% | – |
Financial Health
| Metric | CBT | Rank |
|---|---|---|
| Current Ratio | 1.47x | 5/8 |
| Quick Ratio | 0.97x | 5/8 |
| D/E Ratio | 1.40x | 2/8 |
| Financial Leverage | 2.48x | 2/8 |
| Interest Coverage | 5.4x | 3/8 |
| Working Capital | $530M | 2/8 |
Cash Flow
| Metric | CBT | Rank |
|---|---|---|
| Operating Cash Flow | $497M | 1/9 |
| Free Cash Flow | $281M | 1/5 |
| Capital Spending | -$216M | 5/5 |
| OCF Growth YoY | -23.5% | 5/6 |
| FCF Growth YoY | -19.2% | – |
| FCF/Sales | 7.7% | 2/5 |
| CapEx/Sales | 5.9% | 2/5 |
Operational Efficiency
| Metric | CBT | Rank |
|---|---|---|
| Asset Turnover | 0.91x | 5/7 |
| Inventory Turnover | 5.0x | 7/8 |
| Fixed Assets Turnover | 2.1x | 4/6 |
| Days Inventory | 74 days | 2/8 |
| Payables Period | 87 days | 4/8 |
Income Statement
| Metric | CBT | Rank |
|---|---|---|
| Total Revenue | $3.63B | 1/7 |
| Operating Income | $493M | 1/9 |
| Net Income | $190M | 2/7 |
| R&D Expense | $55M | 2/8 |
| SG&A Expense | $277M | 2/7 |
| Cost of Goods Sold | $2.81B | 1/9 |
Dividend & Shareholder Information
| Metric | CBT | Rank |
|---|---|---|
| Dividends Per Share | $1.88 | – |
| Payout Ratio | 52.8% | – |
| Shares Outstanding | 52M | – |
| Net Income Growth | -55.3% | 4/5 |
| EPS Growth | -58.2% | 4/5 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1.67B | 41.9% of assets |
| Cash & Short-term Investments | $250M | 6.3% of assets |
| Inventory | $566M | 14.2% of assets |
| Total Liabilities | $2.24B | 56.4% of assets |
| Short-term Debt | $465M | 11.7% of assets |
CBT quarterly financials and insider trading
Cabot Corp (CBT) industry peers
Companies classified under the same SEC industry code as Cabot Corp (Miscellaneous Chemical Products): 9 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CBT Cabot Corp | $3.67B | |
| ESI Element Solutions Inc | $7.46B | |
| WDFC Wd 40 Co | $2.97B | |
| FTK Flotek Industries Inc/Cn/ | $886M | |
| ASPI Asp Isotopes Inc. | $318M | |
| OEC Orion S.A. | $224M | |
| ARQ Arq, Inc. | $105M | |
| FSI Flexible Solutions International Inc | $78M | |
| PURE Pure Bioscience, Inc. | $9M |
Where CBT sits on the market map
Cabot Corp (CBT) stock news
Loading...
Cabot Corp (CBT) stock forecast FAQ
What is the Cabot Corp (CBT) stock forecast?
Our AI scores Cabot Corp every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Cabot Corp stock predictions?
For CBT, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 21.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -4.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cabot Corp forecasts updated?
Cabot Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Cabot Corp's industry peers?
9 issuers in our coverage, CBT included, share the SEC industry code Miscellaneous Chemical Products. The largest are: Element Solutions Inc (ESI), Wd 40 Co (WDFC), Flotek Industries Inc/Cn/ (FTK), Asp Isotopes Inc. (ASPI), Orion S.A. (OEC), Arq, Inc. (ARQ).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.